GlassScriptPhysician profile
David M Haybron
NPI 1710963491
$8,793.44
in general payments reported to CMS, 2019-2025
20 companies · $1,286 in 2025
The $1,286 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,350 · 2020: $250 · 2021: $1,158 · 2022: $1,509 · 2023: $1,091 · 2024: $1,150 · 2025: $1,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,525.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,075.63 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abbott Laboratories | $1,975.80 | 2019-2025 | Aveir, Epic, Navitor |
| Medtronic, INC. | $1,904.64 | 2021-2025 | Avalus, Corevalve Evolut R, Penditure |
| Atricure, INC. | $792.57 | 2019-2024 | |
| Abiomed | $704.16 | 2020-2025 | Impella |
| Livanova USA, INC. | $560.46 | 2019-2021 | |
| Medtronic Vascular, INC. | $192.49 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.12 | 2021-2022 | |
| Getinge USA Sales, LLC | $108.15 | 2022-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Ethicon US, LLC | $80.14 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $61.04 | 2021-2024 | Dificid, Zerbaxa, Recarbrio |
| Pfizer INC. | $38.21 | 2024 | |
| Boston Scientific Corporation | $37.39 | 2022-2024 | Watchman Flx |
| Smith+Nephew, INC. | $32.56 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $21.68 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $21.21 | 2022 | |
| Mid-Atlantic Surgical Systems, LLC | $21.20 | 2024 | |
| Shockwave Medical, INC | $20.68 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $16.48 | 2023 | Arcalyst |
| Tetraphase Pharmaceuticals, INC. | $14.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Haybron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.